Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy

Journal of Hypertension

Volumn 34, Issue 9, 2016, Pages 1831-1837

  Okin, Peter M ^a   Kamel, Hooman ^a   Kjeldsen, Sverre E ^b   Devereux, Richard B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

atrium; electrocardiography; fibrillation; hypertension; hypertrophy; stroke

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROCHLOROTHIAZIDE; LOSARTAN; PLACEBO; ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; ECG ABNORMALITY; ELECTROCARDIOGRAPHIC LEFT ATRIAL ABNORMALITY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; P WAVE; P WAVE TERMINAL FORCE IN LEAD V 1; POPULATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX ALLOCATION; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; COMPLICATION; HEART ATRIUM; HEART ATRIUM FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RANDOMIZATION; STROKE;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; ATRIAL FUNCTION, LEFT; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; LOSARTAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RANDOM ALLOCATION; RISK FACTORS; STROKE;

EID: 84973137295     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000989     Document Type: Article

References (36)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: a report of the American Heart Association. Circulation 2014; 129:e28-e292.
2. Soliman EZ, Prineas RJ, Case LD, Zhang ZM, Goff DC Jr. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding of the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2009; 40:1204-1211.
3. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Study. Circulation 1995; 92:835-841.
4. Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke 1999; 30:2019-2024.
5. Barnes ME, Miyasaka Y, Seward JB, Bersh BJ, Rosales AG, Bailey KR, et al. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc 2004; 79:1008-1014.
6. Russo C, Jin Z, Liu R, Iwata S, Tugeu A, Yoshita M, et al. LA volumes and reservoir function are association with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. JACC Cardiovasc Imaging 2013; 6:313-323.
7. Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K, Di Tullio M, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke 2015; 46:1488-1493.
8. Marnane M, Duggan CA, Sheehan OC, Merwick A, Hannon N, Curtin D, et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and Causative Classification system. Stroke 2010; 41:1579-1586.
9. Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014; 13:429-438.
10. Kamel H, Soliman EZ, Heckbert SR, Kronmal RA, Longstreth WT Jr, Nazarian S, et al. P-wave morphology and the risk of incident stroke in the Multi-Ethnic Study of Atherosclerosis. Stroke 2014; 45:2786-2788.
11. Kamel H, Bartz TM, Longstreth WT Jr, Okin PM, Thacker EL, Patton KK, et al. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study. Stroke 2015; 46:711-716.
12. Kamel H, O'Neal WT, Okin PM, Loehr LR, Alonso A, Soliman EZ. Electrocardiograohic left atrial abnormality and incident ischemic stroke subtype in the ARIC study. Ann Neurol 2015; doi: 10.1002/ ana.24482. [Epub ahead of print].
13. Kamel H, Hunter M, Moon YP, Yaghi S, Cheung K, Di Tullio MR, et al. Electrocardiographic left atrial abnormality and risk of stroke: the Northern Manhattan Study. Stroke 2015; 46:3208-3212.
14. Kamel H, Okin PM, Longstreth WT Jr, Elkind MS, Soliman EZ. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol 2015; 11 (3):323-331.
15. Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part V: Electrocardiographic changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 2009; 119:e251-e261.
16. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
17. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, health life-years lost, and age-specific associations in 1.25 million people. Lancet 2014; 383:1899-1911.
18. Piotrowski G, Banach M, Gerdts E, Mikhailidis DP, Hannam S, Gawor R, et al. Left atrial size in hypertension and stroke. J Hypertens 2011; 29:1988-1993.
19. Gerdts E. Left atrial enlargement: a prevalent marker of hypertensive heart disease. Blood Press 2012; 21:71-72.
20. Lee M, Saver JL, Hong K-S, Hao Q, Ovbiagele B. Does achieving an intensive versus usual blood pressure level prevent stroke? Ann Neurol 2012; 71:133-140.
21. Verdecchia P, Reboldi G, Angeli F, Trimarco B, Mancia G, Pogue J, et al. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease. Hypertension 2014; 65:108-114.
22. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels-overview and meta-analyses of randomized trials. J Hypertens 2014; 32:2296-2304.
23. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 1. Overview and meta-analyses of randomized trials. J Hypertens 2014; 32:2285-2295.
24. The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575-1585.
25. Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007; 49:311-316.
26. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995-1003.
27. Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, et al. The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study: rationale, design, and methods. Am J Hypertens 1997; 10:705-713.
28. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995; 25:417-423.
29. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37:161-186.
30. Weinsaft JW, Kochav JD, Kim J, Gurevich S, Volo SC, Afroz A, et al. P wave area for quantitative electrocardiographic assessment of left atrial remodeling. PLoS One 2014; 9 (6):e99178; doi:10.1371/journal.-pone.0099178.
31. Na JO, Shin SY, Lim HE, Choi CU, Kim SH, Kim JW, et al. Impaired transport function of the left atrium and left atrial appendage in cryptogenic stroke patients with atrial septal aneurysm and without patent foramen ovale. Eur J Echocardiog 2011; 12:140-147.
32. Yaghi S, Song C, Gray WA, Furie KL, Elkind MSV, Kamel H. Left atrial appendage function and stroke risk. Stroke 2015; 46:00-10; doi: 10.1161/STOKE.AHA.115.0011273.
33. Akutsu Y, Kaneko K, Kodama Y, Miyoshi F, Li HL, Watanabe N, et al. A combination of P wave electrocardiography and plasma brain natriuretic peptide level for predicting the progression to persistent atrial fibrillation: comparisons of sympathetic activity and left atrial size. J Interv Card Electrophysiol 2013; 38:79-84.
34. Villani GQ, Piepoli M, Rosi A, Capucci A. P-wave dispersion index: a marker of patients with paroxysmal atrial fibrillation. Int J Cardiol 1996; 55:169-175.
35. Dogan U, Dogan EA, Tekinalp M, Tokgoz OS, Aribas A, Akilli H, et al. P-wave dispersion for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Med Sci 2012; 9:108-114.
36. Vural MG, Cetin S, Yilmaz M, Akdemir R, Gunduz H. Relations between left atrial remodeling in young patients with cryptogenic stroke and normal inter-atrial anatomy. J Stroke 2015; 17:312-319.